PPP 784 DURICEF 500 mg (Duricef 500 mg)
Generic Name: cefadroxil
Pill with imprint PPP 784 DURICEF 500 mg is Red / White, Capsule-shape and has been identified as Duricef 500 mg. It is supplied by Bristol-Myers Squibb.
Duricef is used in the treatment of skin and structure infection; kidney infections; bacterial endocarditis prevention; impetigo; skin or soft tissue infection and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Duricef 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PPP 784 DURICEF 500 mg
Duricef
- Generic Name
- cefadroxil
- Imprint
- PPP 784 DURICEF 500 mg
- Strength
- 500 mg
- Color
- Red / White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- First generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00087-0784
More about Duricef (cefadroxil)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: first generation cephalosporins
Consumer resources
- Duricef (Cefadroxil Capsules and Tablets)
- Duricef (Cefadroxil Suspension)
- Duricef (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
